Trade

Samrat Pharmachem share price

High risk
  • 47%Low risk
  • 47%Moderate risk
  • 47%Balanced risk
  • 47%High risk
  • 47%Extreme risk
  • 211.00(-0.80%)
    May 19, 2026 15:15:07 PM IST
    • NSE
    • BSE
  • Vol : 1.28 K (NSE + BSE)
    Last 20 day avg : 1.65 K

Samrat Pharmachem is trading -0.80% lower at Rs 211.00 as compared to its last closing price. Samrat Pharmachem has been trading in the price range of 213.90 & 202.00. Samrat Pharmachem has given -6.42% in this year & 0.02% in the last 5 days. The company posted a net profit of -0.46 Crores in its last quarter.Listed peers of Samrat Pharmachem include Sun Pharmaceutical Industries (-1.21%), Divi's Laboratories (1.27%), Torrent Pharmaceuticals (1.43%).The Mutual Fund holding in Samrat Pharmachem was at -% in . The MF holding has - from the last quarter. The FII holding in Samrat Pharmachem was at 3.24% in 30 Jun 2022. The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 19, 2026, 10:41 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.34
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.14
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.48
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    0.90
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
202.00
Highest
213.90
52 week range
Lowest
190.00
Highest
420.00
Samrat Pharmachem Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,882.15-1.214,51,580.1938.086.060.900.50
Divi's Laboratories
Bullish
6,919.651.271,83,642.5682.2312.050.440.01
Torrent Pharmaceuticals
Bullish
4,457.151.431,50,849.2975.4219.150.8117.62
Cipla
Moderately Bullish
1,410.00-1.161,13,897.3526.063.110.981.11
Dr Reddy's Laboratories
Bullish
1,333.950.191,11,509.7423.652.780.633.22
Samrat Pharmachem Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-30Audited Results
2026-02-13Quarterly Results
2025-11-14Quarterly Results
2025-05-30Audited Results & Final Dividend
2025-02-14Quarterly Results
About the company Samrat Pharmachem
  • IndustryBiotechnology & Drugs
  • ISININE103E01016
  • BSE Code530125
  • NSE Code
Samrat Pharmachem Limited is an India-based manufacturer of iodine salts. The Company is engaged in the business of pharmaceutical chemicals. Its products include 3-5 Di Iodosalicylic Acid, Ammonium Iodide, Cadmium Iodide, Calcium Iodate, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodine, Iodine Monochloride, Iodine Monochloride, Iodoquinol, Methyl Iodide, N-Iodo Succinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate. These products are offered for the agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, painting and textile industries. The Company exports its products to geographics such as the United States, Europe, Africa, Asia, the Middle East and others.
  • Management Info
  • Lalit MehtaExecutive Chairman of the Board, Managing Director
  • Nishant KankariaCompliance Officer, Company Secretary
  • Megh MehtaExecutive Director
  • Rajesh MehtaExecutive Director
Samrat Pharmachem Share Price FAQs

Samrat Pharmachem is trading at 211.00 as on Tue May 19 2026 09:45:07. This is -0.80% lower as compared to its previous closing price of 212.70.

The market capitalization of Samrat Pharmachem is 64.54 Cr as on Tue May 19 2026 09:45:07.

The 52 wk high for Samrat Pharmachem is 420.00 whereas the 52 wk low is 190.00

Samrat Pharmachem can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 28.43
  • Dividend Yield: 0.47%
  • D/E ratio: -

Samrat Pharmachem reported a net profit of 7.11 Cr in 2025.